Treatment of non-alcoholic fatty liver disease
Phase 3
- Conditions
- non alcoholic fatty liver.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT201506222480N6
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Volunteers whom their fatty liver were confirmed by ultrasonography; Don't have any Acute or chronic disease of the liver or bile ducts
Exclusion criteria: Severe weight loss or gain; Pregnancy; ALT serum level 10 times more than normal range.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;FBS. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;Fat mass. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By BIA device.
- Secondary Outcome Measures
Name Time Method HOMA-IR. Timepoint: Before and two months after intervention inception. Method of measurement: Calculate by HOMA index equation.